NCT02974660View on ClinicalTrials.gov

Protamine Sulfate During Transcatheter Aortic Valve Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

September 30, 2020

Conditions
Aortic Valve Stenosis
Interventions
DRUG

Protamine sulfate

DRUG

0.9% NaCl

Trial Locations (1)

Unknown

First Department of Cardiology, Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT02974660 - Protamine Sulfate During Transcatheter Aortic Valve Implantation | Biotech Hunter | Biotech Hunter